(READ) Review shows Merck’s newly-approved pill for Covid-19, only 30% effective
Below is an excerpt from Medpage Today. With the release of updated data, oral antiviral molnupiravir to treat high-risk COVID-19 showed only a 30% reduction in the risk of hospitalization and death, according to briefing documents from FDA staff. The […]
(READ) Review shows Merck’s newly-approved pill for Covid-19, only 30% effective Read More »








